Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
Quick Stats
Jan 30, 202652.2
AI Score
HOLD2.84
Volume Ratio
Mar 09, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
LCTX Stock Summary
Last updated Jan 30, 2026
LCTX is currently trading at $1.48, positioned above its 200-day moving average of $1.26, indicating a long-term uptrend. The stock has a 52-week range of $0.3651 to $2.09.
Technical Analysis: The 50-day moving average stands at $1.68, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 35.354, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.05, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LCTX at 52.2/100 with a HOLD recommendation.
LCTX (Lineage Cell Therapeutics, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 35.354 |
| CMF (20) | -0.05 |
| ROC (10) | -10.303 |
| ADX (14) | 14.439 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.04 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -93.846 |
| MFI (14) | 33.53 |
LCTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LCTX Price vs Max Options Open Interest
LCTX Max Change In Options Open Interest
LCTX Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LCTX Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LCTX Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LCTX Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Lineage Cell Therapeutics, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
LCTX Moving Averages Analysis
Lineage Cell Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
LCTX (Lineage Cell Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.61 |
| 20 | 1.66 |
| 30 | 1.67 |
| 50 | 1.68 |
| 100 | 1.68 |
| 200 | 1.26 |
LCTX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 363.9 million |
| Earnings/Share ($) | -0.29 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.2883 |
| EPS Estimate Next Year ($) | -0.0567 |
| WallStreet Target Price ($) | 4.1667 |
| Most Recent Quarter |